FdaApplication
ANDA 217250
Identifiers
- fda_app_no: ANDA217250
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 2024-10-01 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERIBULIN MESYLATE | ERIBULIN MESYLATE | 1MG/2ML (0.5MG/ML) | SOLUTION;INTRAVENOUS |
1 product